Bioequivalence studies of generic drug products are considered surrogate measures for FDA approval. Read this blog to to know the challenges faced by Bioequivalence studies during covid-19.
https://kwirmedia.com/covid-19-challenges-and-mitigation-for-your-bioequivalence-study-testing/
 

comments (0)

63 more from nebiolab